GHRH AnalogHover to zoomQualified Research Reference
Tesamorelin
Tesamorelin is documented for controlled research models and literature-based evaluation only.
- Regular
- $170.00
- Elite Member−10%
- $153.00
Tesamorelin is a synthetic 44-amino-acid GHRH analog supplied as a lyophilized peptide for research use. Produced under controlled conditions.
Investigated in GHRH receptor signaling, visceral adipose research, and lipid-metabolism pathway modeling.
Research Use Only. This product is intended exclusively for laboratory research and is not approved for human or veterinary use.
Tesamorelin: investigational profile.
Research Mechanism
A stabilized 44-residue GHRH analog investigated for pituitary GHRH-receptor activity, endogenous GH pulse amplitude, and downstream growth-hormone-pathway signaling — particularly in visceral-adipose research models.
Investigational Profile
Published characterization has accumulated since the late 2000s and it is one of the more thoroughly documented GHRH analogs in the endocrine literature.
Research Study Window
Adipose and axis-marker endpoints are commonly observed across eight- to twenty-six-week windows to capture full GH-pathway adaptation.
Pairs With
Ipamorelin
Ingredients, disclosed.
Every compound and formulation strength documented without proprietary blends.
Composition, documented.
- Molecular Formula
- C221H366N72O67S
- Molar Mass
- 5135.8 g/mol
- Amino Acid Sequence
- trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-OH
- Synonyms
- TH9507, GHRH(1-44) analog
- Solubility
- Water-soluble
- Organoleptic Profile
- White to off-white powder
- Composition
- Lyophilized powder
